Development of a decision-support tool to quantify authorship contributions in clinical trial publications

IF 1.6 Q2 COMMUNICATION Science Editing Pub Date : 2022-02-20 DOI:10.6087/kcse.259
Sam T. Mathew, H. I. A. Razack, Prasanth Viswanathan
{"title":"Development of a decision-support tool to quantify authorship contributions in clinical trial publications","authors":"Sam T. Mathew, H. I. A. Razack, Prasanth Viswanathan","doi":"10.6087/kcse.259","DOIUrl":null,"url":null,"abstract":"Purpose: This study aimed to develop a decision-support tool to quantitatively determine authorship in clinical trial publications.Methods: The tool was developed in three phases: consolidation of authorship recommendations from the Good Publication Practice (GPP) and International Committee of Medical Journal Editors (ICMJE) guidelines, identifying and scoring attributes using a 5-point Likert scale or a dichotomous scale, and soliciting feedback from editors and researchers.Results: The authorship criteria stipulated by the ICMJE and GPP recommendations were categorized into 2 Modules. Criterion 1 and the related GPP recommendations formed Module 1 (sub-criteria: contribution to design, data generation, and interpretation), while Module 2 was based on criteria 2 to 4 and the related GPP recommendations (sub-criteria: contribution to manuscript preparation and approval). The two modules with relevant sub-criteria were then differentiated into attributes (n = 17 in Module 1, n = 12 in Module 2). An individual contributor can be scored for each sub-criterion by summing the related attribute values; the sum of sub-criteria scores constituted the module score (Module 1 score: 70 [contribution to conception or design of the study, 20; data acquisition, 7; data analysis, 27; interpretation of data, 16]; Module 2 score: 50 [content development, 27; content review, 18; accountability, 5]). The concept was integrated into Microsoft Excel with adequate formulae and macros. A threshold of 50% for each sub-criterion and each module, with an overall score of 65%, is predefined as qualifying for authorship.Conclusion: This authorship decision-support tool would be helpful for clinical trial sponsors to assess and provide authorship to deserving contributors.","PeriodicalId":43802,"journal":{"name":"Science Editing","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2022-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Editing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6087/kcse.259","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"COMMUNICATION","Score":null,"Total":0}
引用次数: 1

Abstract

Purpose: This study aimed to develop a decision-support tool to quantitatively determine authorship in clinical trial publications.Methods: The tool was developed in three phases: consolidation of authorship recommendations from the Good Publication Practice (GPP) and International Committee of Medical Journal Editors (ICMJE) guidelines, identifying and scoring attributes using a 5-point Likert scale or a dichotomous scale, and soliciting feedback from editors and researchers.Results: The authorship criteria stipulated by the ICMJE and GPP recommendations were categorized into 2 Modules. Criterion 1 and the related GPP recommendations formed Module 1 (sub-criteria: contribution to design, data generation, and interpretation), while Module 2 was based on criteria 2 to 4 and the related GPP recommendations (sub-criteria: contribution to manuscript preparation and approval). The two modules with relevant sub-criteria were then differentiated into attributes (n = 17 in Module 1, n = 12 in Module 2). An individual contributor can be scored for each sub-criterion by summing the related attribute values; the sum of sub-criteria scores constituted the module score (Module 1 score: 70 [contribution to conception or design of the study, 20; data acquisition, 7; data analysis, 27; interpretation of data, 16]; Module 2 score: 50 [content development, 27; content review, 18; accountability, 5]). The concept was integrated into Microsoft Excel with adequate formulae and macros. A threshold of 50% for each sub-criterion and each module, with an overall score of 65%, is predefined as qualifying for authorship.Conclusion: This authorship decision-support tool would be helpful for clinical trial sponsors to assess and provide authorship to deserving contributors.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
开发决策支持工具,量化临床试验出版物的作者贡献
目的:本研究旨在开发一种决策支持工具,定量确定临床试验出版物的作者身份。方法:该工具的开发分三个阶段:整合来自良好出版规范(GPP)和国际医学期刊编辑委员会(ICMJE)指南的作者推荐,使用5分李克特量表或二分类量表识别和评分属性,并征求编辑和研究人员的反馈。结果:ICMJE和GPP推荐的作者标准分为2个模块。标准1和相关的GPP建议构成模块1(子标准:对设计、数据生成和解释的贡献),而模块2基于标准2至4和相关的GPP建议(子标准:对手稿准备和批准的贡献)。然后将具有相关子标准的两个模块划分为属性(模块1中n = 17,模块2中n = 12)。通过将相关属性值相加,可以对每个子标准进行评分;子标准得分之和构成模块得分(模块1得分:70分[对研究概念或设计的贡献,20分;数据采集,7分;数据分析,27;数据解释,16];模块2得分:50分【内容开发】27分;内容复习,18分;问责制,5])。这个概念被集成到Microsoft Excel中,并提供了足够的公式和宏。每个子标准和每个模块的阈值为50%,总分为65%,预定义为作者资格。结论:该作者决策支持工具有助于临床试验申办者评估并为有资格的作者提供作者资格。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Science Editing
Science Editing COMMUNICATION-
CiteScore
2.90
自引率
20.00%
发文量
31
审稿时长
10 weeks
期刊介绍: Science Editing (Sci Ed) is the official journal of the Korean Council of Science Editors (https://kcse.org) and Council of Asian Science Editors (https://asianeditor.org). It aims to improve the culture and health of human being by promoting the quality of editing and publishing scientific, technical, and medical journals. Expected readers are editors, publishers, reviewers, and authors of the journals around the world; however, specially focused to those in Asia. Since scholarly journals in Asia are mostly published by the academic societies, universities, or non-profit organizations, Sci Ed is sought to play a role in journal development. The number of publications from Asia is increasing rapidly and overpass that of other continents; meanwhile, the number of international journals and highly appreciated journals is yet to be coming forward. It is task of Asian editors to pledge the journal quality and broaden the visibility and accessibility. Therefore, its scope includes the followings in the field of science, technology, and medicine.
期刊最新文献
Impact factor surge in Korean medical journals during the COVID-19 era: a bibliometric study Trends in research on ChatGPT and adoption-related issues discussed in articles: a narrative review Get Full Text Research (GetFTR): can it be a good tool for researchers? What is next for “transformation, trust, and transparency”? Korean scholarly journal editors’ and publishers’ attitudes towards journal data sharing policies and data papers (2023): a survey-based descriptive study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1